# \#epidemiology

**URL:** https://rcop.michaeljfox.org/tag/epidemiology/19.md

[Latest](https://rcop.michaeljfox.org/latest.md) · [Categories](https://rcop.michaeljfox.org/categories.md) · [Tags](https://rcop.michaeljfox.org/tags.md)

---

## [Epidemiology 101](https://rcop.michaeljfox.org/t/epidemiology-101/1487)

<div class="topic-metadata">

**Author:** [@fbbriggs](https://rcop.michaeljfox.org/u/fbbriggs)\
**Replies:** 2\
**Last updated:** [April 9, 2026, 7:16pm UTC](https://rcop.michaeljfox.org/t/epidemiology-101/1487 "2026-04-09T19:16:13Z")

</div>

Hi all, I am creating a few video vignettes to cover key epi concepts using NotebookLM and curated resources. I have a few areas that I will post on, but please let me know what are other burning questios you might have…

---

## [Need your input on epidemiology learning modules/content](https://rcop.michaeljfox.org/t/need-your-input-on-epidemiology-learning-modules-content/1295)

<div class="topic-metadata">

**Author:** [@fbbriggs](https://rcop.michaeljfox.org/u/fbbriggs)\
**Replies:** 4\
**Last updated:** [November 8, 2025, 10:02pm UTC](https://rcop.michaeljfox.org/t/need-your-input-on-epidemiology-learning-modules-content/1295 "2025-11-08T22:02:45Z")

</div>

Hi all, As part of the Data Modality & Methodology Task force, we would like to develop short, digestible yet informative content (e.g. 15 minutes videos or vignettes) on key epidemiologic concepts relevant to Parkinson…

---

## [Competing risk!](https://rcop.michaeljfox.org/t/competing-risk/1001)

<div class="topic-metadata">

**Author:** [@hirotaka](https://rcop.michaeljfox.org/u/hirotaka)\
**Replies:** 3\
**Last updated:** [May 19, 2025, 12:40pm UTC](https://rcop.michaeljfox.org/t/competing-risk/1001 "2025-05-19T12:40:37Z")

</div>

Sometimes I wonder whether it’s appropriate to focus solely on the event of interest in survival analysis. For example, if I’m studying dementia, is it valid to simply censor individuals who die during follow-up? I rece…